AOD9604 5AD 5mg*10vials
AOD9604 is a modified fragment of human growth hormone, specifically designed to target fat metabolism without the growth-related side effects associated with full-length HGH. It represents a specialized research peptide focused on lipolytic pathways.
The 5mg single-vial specification offers a moderate concentration step up from the standard 2mg. This formulation is well-suited for medium-dose gradient studies, extended fat metabolism experiments, and researchers looking to reduce the number of vials needed for longer experimental timelines. The higher content per vial provides greater preparation flexibility for dose escalation protocols.
Through its targeted receptor pathway, AOD9604 supports research into fat oxidation, lipolysis mechanisms, and metabolic regulation related to adipose tissue breakdown. It is designed to study fat mobilization pathways without influencing blood sugar levels or muscle growth parameters.
This product is supplied as sterile lyophilized powder in glass vials, formulated for reconstitution with bacteriostatic water. Each batch undergoes comprehensive purity testing, with a certificate of analysis provided.
10 vials per pack, designed for medium-scale laboratory research and extended fat metabolism studies.